Tracey Simon MD
Gastrointestinal Cancer, Hepatology & Liver Transplantation
Physician
Join to View Full Profile
55 Fruit StreetBoston, MA 02114
Phone+1 617-724-2000
Dr. Simon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Gastroenterology, 2018
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2012 - 2015
The Warren Alpert Medical School of Brown UniversityClass of 2012
Certifications & Licensure
MA State Medical License 2015 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis.Robert M Wilechansky, Prasanna K Challa, Xijing Han, Xinwei Hua, Alisa K Manning
Cancer Prevention Research. 2025-04-01 - Statin Use and Risk of Hepatocellular Carcinoma and Liver Fibrosis in Chronic Liver Disease.Jonggi Choi, Vy H Nguyen, Eric Przybyszewski, Jiunn Song, Allison Carroll
JAMA Internal Medicine. 2025-03-17 - 1 citationsAGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals.Faisal S Ali, Mindie H Nguyen, Ruben Hernaez, Daniel Q Huang, Julius Wilder
Gastroenterology. 2025-02-01
Press Mentions
Preventing Hepatitis B Reactivation: Updated Clinical Guidance from AGAMarch 7th, 2025- Could Aspirin Lower Your Liver Cancer Risk?May 18th, 2022
Low-Dose Aspirin May Lower Risk of Hepatocellular Carcinoma & Liver-Related MortalityMarch 16th, 2020- Join now to see all
Grant Support
- The Comparative Effectiveness and Safety of Oral Anticoagulants in Patients with Cirrhosis and Atrial FibrillationBRIGHAM AND WOMEN'S HOSPITAL2023–2028
- Aspirin and Novel Lipid Mediators in Nonalcoholic Fatty Liver DiseaseMASSACHUSETTS GENERAL HOSPITAL2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
